HKeyBio Launches the HKEY-AIDMD 3.0–a Next-Generation Platform to Crack the Toughest Challenge in Autoimmune and Allergy Drug Development: Multi-target Combination Strategy Optimization
The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and…
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…